When mRNA vaccines were first rolled out, the biomedical community was elated at the prospect of leveraging lipid nanoparticles to circumvent the body’s immune defenses and deliver mRNA fully intact into the cells. However, as researchers look closer into the science behind genetic therapies, a surprising discovery has emerged: the lipid nanoparticles used in mRNA formulations may not be as benign as initially thought. These contaminants pose as "self assembling lipids for the purpose of transfection."
Concerns about lipid nanoparticles: Expert Analysis by Dr. Anne Ulrich: Dr. Ulrich, a biochemistry professor, provided an analysis in the International Journal of Vaccine Theory, Practice, and Research (IJVTPR), explaining the structures observed in mRNA vaccines.
